No Picture
News

Catalyst Biosciences Announces CFI Variant Presentations at Two Upcoming Scientific Conferences

SOUTH SAN FRANCISCO, Calif., Oct. 29, 2021 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that Grant Blouse, Ph.D., chief scientific officer, will present at two upcoming scientific conferences, the 5th Complement-based Drug […]

No Picture
News

Oncternal Therapeutics to Provide Business Update and Report Third Quarter 2021 Financial Results

SAN DIEGO, Oct. 29, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report third quarter 2021 financial […]

No Picture
Boston Cambridge Biotech Trending News

Intracellular targets, eye cancer therapy and light-activated skincare: Here’s the latest on biotech IPOs

Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here. The busy IPO season shows no sign of slowing, with three more biotechs trick-or-treating for their own stock tickers […]

No Picture
Los Angeles Biotech Trending News

AIVITA Biomedical’s Stem Cell-Derived Retina Transplant Restores Vision Loss in Preclinical Study

IRVINE, Calif.: IRVINE, Calif., Oct. 29, 2021 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced the publication of the peer-reviewed manuscript, "Co-grafts of Human Stem Cell Derived […]

News

Alnylam’s John Maraganore isn’t the only CEO to leave his post; CRISPR’s chief commercial officer takes the helm at a protein degradation player

John Maraganore The departure of a number of CEOs is the prevailing theme that kicks off this week’s installment: In a stunner, Alnylam CEO John Maraganore announced that Yvonne Greenstreet will be his successor at […]